Ozempic / Mounjaro vs Generic Peptides
Is generic semaglutide or tirzepatide just as effective as the brand-name version? Here's what you need to know.
What's the Difference?
Ozempic and Wegovy are brand-name versions of semaglutide made by Novo Nordisk. Mounjaro and Zepbound are brand-name tirzepatide made by Eli Lilly. These are FDA-approved, pharmaceutical-grade formulations sold through licensed pharmacies at significant cost ($800 to 1,200/month without insurance in the US).
Generic or research-grade versions contain the identical active molecule, the same amino acid sequence and chemical structure. The difference lies in manufacturing standards, inactive ingredients (excipients), and the regulatory oversight applied during production.
Brand vs Generic: Side-by-Side
| Factor | Brand (Ozempic/Mounjaro) | Generic/Research Grade |
|---|---|---|
| Active molecule | Identical | Identical |
| FDA approval | Yes | No (research use) |
| Manufacturing oversight | GMP certified | Varies by supplier |
| Price (Vietnam) | ~$800 to 1,200/month | ~$138 to 205/month |
| COA verification | Pharmacy-issued | Third-party lab (must request) |
| Availability | Pharmacy (requires Rx) | Online suppliers |
| Formulation | Pen injector | Lyophilized vial |
Is Generic Safe?
Generic research-grade peptides can be safe when sourced from a reputable supplier with third-party COA verification. The key risks are:
- ⚠Underdosing: vial contains less than labeled (you get no results but think it doesn't work)
- ⚠Contamination: improper manufacturing introduces impurities
- ⚠Wrong compound: product is substituted or mislabeled
- ⚠Improper storage: degradation before you receive it
These risks are substantially mitigated by using a COA-verified supplier with cold-chain shipping. Many users in Vietnam and internationally report equivalent results from generic vs brand-name versions when sourced responsibly.